Algenex SL, a private biotechnology company, opened a new facility in Tres Cantos, Spain at an inauguration ceremony attended by the Spanish Minster of Science and innovation, Pedro Duque, the vice president of the Madrid Region (Comunidad de Madrid), Ignacio Aguado and representatives of the pharmaceutical industry in Spain. The new facility allows Algenex to produce up to 3.5kg of recombinant proteins, equivalent to around 100 million vaccine doses across animal and human health.   The facilit...